← Open Payments lookup

ALLISON CASSETTA: Open Payments

NPI 1467917211 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,536 in 145 payments from 20 companies in 2025. Trend: 2023 $239 · 2024 $2,310 · 2025 $3,536

Food & beverage: $3,536
CompanyPaymentsAmount
ABBVIE INC.38$920
Gilead Sciences, Inc.17$483
Salix Pharmaceuticals, a division of Bausch Health US, LLC18$309
Janssen Biotech, Inc.11$258
Regeneron Healthcare Solutions, Inc.9$226
Regeneron Pharmaceuticals, Inc.2$215
Ardelyx, Inc.7$210
Takeda Pharmaceuticals U.S.A., Inc.8$186
Madrigal Pharmaceuticals7$171
QOL Medical, LLC9$171

Products named: DUPIXENT, SKYRIZI, XIFAXAN, RINVOQ, TREMFYA, IBSRELA, REZDIFFRA, Sucraid.

Industry payments across CO — which companies pay providers there.